Determination of platinum drug release and liposome stability in human plasma by CE-ICP-MS

International Journal of Pharmaceutics

Volumn 449, Issue 1-2, 2013, Pages 95-102

  Nguyen, Tam T T N ^a   Østergaard, Jesper ^a   Stürup, Stefan ^a   Gammelgaard, Bente ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

CE ICP MS; Cisplatin; Human plasma; In vitro release; Liposomes; Stability

Indexed keywords

CISPLATIN; LIPOSOME; OXALIPLATIN; PLATINUM;

AQUEOUS SOLUTION; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; DRUG HYDROLYSIS; DRUG RELEASE; DRUG STABILITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CISPLATIN; ELECTROPHORESIS, CAPILLARY; HUMANS; LIPOSOMES; MASS SPECTROMETRY; ORGANOPLATINUM COMPOUNDS; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS;

EID: 84877708042     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.03.055     Document Type: Article

References (34)

1. T.M. Allen, and L.G. Cleland Serum-induced leakage of liposome contents Biochim. Biophys. Acta Biomembr. 597 1980 418 426
2. A.D. Bangham, and R.W. Horne Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope J. Mol. Biol. 8 1964 660 668
3. G.V. Betageri, and D.L. Parsons Drug encapsulation and release from multilamellar and unilamellar liposomes Int. J. Pharm. 81 1992 235 241
4. B.J. Boyd Characterisation of drug release from cubosomes using the pressure ultrafiltration method Int. J. Pharm. 260 2003 239 247
5. D. Chen, D.L. Cole, and G.S. Srivatsa Determination of free and encapsulated oligonucleotides in liposome formulated drug product J. Pharmaceut. Biomed. 22 2000 791 801
6. B. Chimanuka, M. Gabriels, M.R. Detaevernier, and J.A. Plaizier-Vercammen Preparation of beta-artemether liposomes their HPLC-UV evaluation and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice J. Pharmaceut. Biomed. 28 2002 13 22
7. K.A. Edwards, and A.J. Baeumner Analysis of liposomes Talanta 68 2006 1432 1441
8. T.J. Evjen, E.A. Nilssen, S. Rognvaldsson, M. Brandl, and S.L. Fossheim Distearoylphosphatidylethanolamine-based liposomes for ultrasound-mediated drug delivery Eur. J. Pharm. Biopharm. 75 2010 327 333
9. T. Falta, G. Koellensperger, A. Standler, W. Buchberger, R.M. Mader, and S. Hann Quantification of cisplatin carboplatin and oxaliplatin in spiked human plasma samples by ICP-SFMS and hydrophilic interaction liquid chromatography (HILIC) combined with ICP-MS detection J. Anal. At. Spectrom. 24 2009 1336 1342
10. A.-M. Florea, and D. Büsselberg Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects Cancers 3 2011 1351 1371
11. U. Franzen, T.T.T.N. Nguyen, C. Vermehren, B. Gammelgaard, and J. Østergaard Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: encapsulation and leakage J. Pharmaceut. Biomed. 55 2011 16 22
12. U. Franzen, and J. Østergaard Physico-chemical characterization of liposomes and drug substance liposome interactions in pharmaceutics using capillary electrophoresis and electrokinetic chromatography J. Chromatogr. A 1267 2012 32 44
13. B. Gammelgaard, H.R. Hansen, S. Stürup, and C. Møller The use of inductively coupled plasma mass spectrometry as a detector in drug metabolism studies Expert Opin. Drug Metods 4 2008 1187 1207
14. C. Grabielle-Madelmont, S. Lesieur, and M. Ollivon Characterization of loaded liposomes by size exclusion chromatography J. Biochem. Biophys. Methods 56 2003 189 217
15. N. Griese, G. Blaschke, J. Boos, and G. Hempel Determination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresis J. Chromatogr. A 979 2002 379 388
16. M. Groessl, M. Terenghi, A. Casini, L. Elviri, R. Lobinski, and P.J. Dyson Reactivity of anticancer metallodrugs with serum proteins: new insights from size exclusion chromatography-ICP-MS and ESI-MS J. Anal. At. Spectrom. 25 2010 305 313
17. S. Hann, G. Koellensperger, Z. Stefanka, G. Stingeder, M. Furhacker, W. Buchberger, and R.M. Mader Application of HPLC-ICP-MS to speciation of cisplatin and its degradation products in water containing different chloride concentrations and in human urine J. Anal. At. Spectrom. 18 2003 1391 1395
18. R.D. Hofheinz, S.U. Gnad-Vogt, U. Beyer, and A. Hochhaus Liposomal encapsulated anti-cancer drugs Anti-Cancer Drug 16 2005 691 707
19. L. Jia, M. Garza, H. Wong, D. Reimer, T. Redelmeier, J.B. Camden, and S.D. Weitman Pharmacokinetic comparison of intravenous carbendazim and remote loaded carbendazim liposomes in nude mice J. Pharmaceut. Biomed. 28 2002 65 72
20. C. Larsen, S.W. Larsen, H. Jensen, A. Yaghmur, and J. Østergaard Role of in vitro release models in formulation development and quality control of parenteral depots Expert Opin. Drug Deliv. 6 2009 1283 1295
21. W.G. Love, N. Amos, B.D. Williams, and I.W. Kellaway High performance liquid chromatographic analysis of liposome stability J. Microencapsul. 7 1990 105 112
22. T.T.T.N. Nguyen, J. Østergaard, S. Stürup, and B. Gammelgaard Investigation of a liposomal oxaliplatin drug formulation by capillary electrophoresis hyphenated to inductively coupled plasma mass spectrometry (CE-ICP-MS) Anal. Bioanal. Chem. 402 2012 2131 2139
23. T.T.T.N. Nguyen, J. Østergaard, S. Stürup, and B. Gammelgaard Metallomics in drug development: characterization of a liposomal cisplatin drug formulation in human plasma by CE-ICP-MS Anal. Bioanal. Chem. 405 2012 1845 1854
24. T.T.T.N. Nguyen, S. Stürup, J. Østergaard, U. Franzen, and B. Gammelgaard Simultaneous measurement of phosphorus and platinum by size exclusion chromatography coupled to inductively coupled plasma mass spectrometry (SEC-ICPMS) using xenon as reactive collision gas for characterization of platinum drug liposomes J. Anal. At. Spectrom. 26 2011 1466 1473
25. A. Rajeswaran, A. Trojan, B. Burnand, and M. Giannelli Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials Lung Cancer 59 2008 1 11
26. V.P. Torchilin, and V. Weissig Liposomes. A Practical Approach second ed. 2003 Oxford University Press New York
27. S. Vemuri, C.D. Yu, S. Pushpala, and N. Roosdorp Drug release rate method for a liposome preparation Drug Dev. Ind. Pharm. 17 1991 183 192
28. Vikbjerg, A.F., Petersen, S.A., Melander, F., Henriksen, J.R., Joergensen, K., 2009. Liposomes For Drug Delivery And Methods For Preparation Thereof. WO2009EP56297 20090525 [WO2009141450 (A2)]. Ref Type: Patent.
29. C. Washington Evaluation of non-sink dialysis methods for the measurement of drug release from colloids: effects of drug partition Int. J. Pharm. 56 1989 71 74
30. C. Washington Drug release from microdisperse systems: a critical review Int. J. Pharm. 58 1990 1 12
31. C. Washington, and F. Koosha Drug release from microparticulates; deconvolution of measurement errors Int. J. Pharm. 59 1990 79 82
32. C. Xiao, X. Qi, Y. Maitani, and T. Nagai Sustained release of cisplatin from multivesicular liposomes: potentiation of antitumor efficacy against S180 murine carcinoma J. Pharm. Sci. 93 2004 1718 1724
33. X. Xu, M.A. Khan, and D.J. Burgess A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes Int. J. Pharm. 426 2012 211 218
34. W.C. Zamboni Liposomal, nanoparticle, and conjugated formulations of anticancer agents Clin. Cancer Res. 11 2005 8230 8234